References
- Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med 2004;140:945-50. https://doi.org/10.7326/0003-4819-140-11-200406010-00035
- Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, et al. Diabetic retinopathy. Diabetes Care 2003;26:226-9. https://doi.org/10.2337/diacare.26.1.226
- Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathology. J Dent Res 2006;85:15-21. https://doi.org/10.1177/154405910608500103
- Diabetes and periodontal diseases. Committee on Research, Science and Therapy. American Academy of Periodontology. J Periodontol 2000;71:664-78. https://doi.org/10.1902/jop.2000.71.4.664
- Pradhan AD, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? Eur Heart J 2002;23:831-4. https://doi.org/10.1053/euhj.2001.3052
- Bluher M, Fasshauer M, Tonjes A, Kratzsch J, Schon MR, Paschke R. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 2005;113:534-7. https://doi.org/10.1055/s-2005-872851
- Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-7. https://doi.org/10.1902/jop.2000.72.9.1221
- Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26(3 Pt 2):230-42. https://doi.org/10.1111/j.1600-0765.1991.tb01649.x
- Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003;74:1007-16. https://doi.org/10.1902/jop.2003.74.7.1007
- D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 2004;39:236-41. https://doi.org/10.1111/j.1600-0765.2004.00731.x
- Sorsa T, Ingman T, Suomalainen K, Haapasalo M, Konttinen YT, Lindy O, et al. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect Immun 1992;60:4491-5.
- Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516. https://doi.org/10.1146/annurev.cellbio.17.1.463
- Park JW, Lee JM. The comparison of IL-6, elastase and alpha1-PI expressions in human chronic periodontitis with type 2 diabetes mellitus. J Korean Acad Periodontol 2007;37(Suppl):325-38. https://doi.org/10.5051/jkape.2007.37.Suppl.325
- Borden P, Heller RA. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 1997;7:159-78. https://doi.org/10.1615/CritRevEukarGeneExpr.v7.i1-2.90
- Brinckerhoff CE, Rutter JL, Benbow U. Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-30.
- Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006;206:1-8. https://doi.org/10.1002/jcp.20431
- Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448-64. https://doi.org/10.1002/path.1400
- Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267-83. https://doi.org/10.1016/S0167-4838(99)00279-4
- Williamson RA, Marston FA, Angal S, Koklitis P, Panico M, Morris HR, et al. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP). Biochem J 1990;268:267-74. https://doi.org/10.1042/bj2680267
- Goldberg GI, Strongin A, Collier IE, Genrich LT, Marmer BL. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-91.
- Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, Schade van Westrum S, et al. The TIMP2 membrane type 1 metal-loproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998;273:871-80. https://doi.org/10.1074/jbc.273.2.871
- Muhlemann HR, Son S. Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helv Odontol Acta 1971;15:107-13.
- Cho JY, Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, et al. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 2000;7:740-9.
- Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002;30:182-92. https://doi.org/10.1034/j.1600-0528.2002.300304.x
- Cutler CW, Shinedling EA, Nunn M, Jotwani R, Kim BO, Nares S, et al. Association between periodontitis and hyperlipidemia: cause or effect? J Periodontol 1999;70:1429-34. https://doi.org/10.1902/jop.1999.70.12.1429
- Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest 1993;91:1351-7. https://doi.org/10.1172/JCI116336
- Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacology 1999;42:23-30. https://doi.org/10.1016/S0162-3109(99)00007-7
- Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504. https://doi.org/10.1097/00003246-199903000-00024
- Povoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, et al. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005;25:804-12. https://doi.org/10.1183/09031936.05.00071704
- Hsueh WA, Bruemmer D. Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease. Hypertension 2004;43:297-305. https://doi.org/10.1161/01.HYP.0000113626.76571.5b
- Zucker S, Pei D, Cao J, Lopez-Otin C. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 2003;54:1-74.
- Seiki M, Yana I. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci 2003;94:569-74. https://doi.org/10.1111/j.1349-7006.2003.tb01484.x
- Wu YI, Munshi HG, Sen R, Snipas SJ, Salvesen GS, Fridman R, et al. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem 2004;279:8278-89. https://doi.org/10.1074/jbc.M311870200
- Itoh Y, Seiki M. MT1-MMP: an enzyme with multidimensional regulation. Trends Biochem Sci 2004;29:285-9. https://doi.org/10.1016/j.tibs.2004.04.001
- Song W, Ergul A. Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size. Cardiovasc Diabetol 2006;5:3. https://doi.org/10.1186/1475-2840-5-3
- McLennan SV, Martell SY, Yue DK. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation. Diabetologia 2000;43:642-8. https://doi.org/10.1007/s001250051353
Cited by
- Relationship of tooth mortality and implant treatment in Type 2 diabetes mellitus patients in Korean adults vol.5, pp.1, 2013, https://doi.org/10.4047/jap.2013.5.1.51
- A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes vol.40, pp.14, 2011, https://doi.org/10.1111/jcpe.12059
- A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes vol.84, pp.4, 2011, https://doi.org/10.1902/jop.2013.134005
- Local inflammatory reactions in patients with diabetes and periodontitis vol.69, pp.1, 2011, https://doi.org/10.1111/prd.12089
- Levels of Myeloperoxidase and Metalloproteinase-9 in Gingival Crevicular Fluid from Diabetic Subjects with and without Stage 2, Grade B Periodontitis vol.2019, pp.None, 2011, https://doi.org/10.1155/2019/5613514
- The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis vol.68, pp.4, 2011, https://doi.org/10.1007/s00011-019-01220-4
- Chronic Periodontitis in Patients with Type 2 Diabetes: Analysis of the FokI Polymorphism and Perception of Quality of Life vol.20, pp.None, 2011, https://doi.org/10.1590/pboci.2020.149
- Interrelation between plasma membrane calcium ATPase-1 and inflammatory mediators expression in gingival tissue depending on severity of periodontitis vol.44, pp.1, 2020, https://doi.org/10.21851/obr.44.01.202003.23
- Diabetes as a risk factor for periodontal disease—plausible mechanisms vol.83, pp.1, 2011, https://doi.org/10.1111/prd.12298
- Evaluation of superoxide dismutase 3, heme-oxygenase, and myeloperoxidase expression levels associated with oxidative stress in chronic periodontitis vol.45, pp.3, 2011, https://doi.org/10.21851/obr.45.03.202109.99